Accendra Health, Inc.ACHNYSE
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank67
3Y CAGR-7.9%
5Y CAGR-26.7%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-7.9%/yr
Quarterly compound
5Y CAGR
-26.7%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.68% |
| Q3 2025 | 2.25% |
| Q2 2025 | -74.09% |
| Q1 2025 | -2.37% |
| Q4 2024 | 292.53% |
| Q3 2024 | 4.00% |
| Q2 2024 | -74.72% |
| Q1 2024 | -1.64% |
| Q4 2023 | 2.49% |
| Q3 2023 | 1.11% |
| Q2 2023 | 1.60% |
| Q1 2023 | -1.11% |
| Q4 2022 | 2.15% |
| Q3 2022 | -0.10% |
| Q2 2022 | 3.87% |
| Q1 2022 | -2.44% |
| Q4 2021 | -1.40% |
| Q3 2021 | 0.51% |
| Q2 2021 | 7.00% |
| Q1 2021 | -1.49% |
| Q4 2020 | 7.95% |
| Q3 2020 | 21.03% |
| Q2 2020 | -14.84% |
| Q1 2020 | -3.10% |
| Q4 2019 | -4.45% |
| Q3 2019 | -3.53% |
| Q2 2019 | 1.10% |
| Q1 2019 | 10.76% |
| Q4 2018 | -13.89% |
| Q3 2018 | 0.27% |
| Q2 2018 | 3.61% |
| Q1 2018 | -0.72% |
| Q4 2017 | 2.39% |
| Q3 2017 | 3.00% |
| Q2 2017 | -2.69% |
| Q1 2017 | -1.68% |
| Q4 2016 | -1.96% |
| Q3 2016 | -2.74% |
| Q2 2016 | 1.14% |
| Q1 2016 | -1.29% |